«After just three treatment cycles,
we saw tumor markers plummet and some patients» tumors shrink significantly in just nine weeks,» said Gayle Jameson, nurse practitioner and principal investigator of the clinical trial, who is highly encouraged by the response.
Not exact matches
They found that injecting into the carotid artery breast cancer cells that express
markers allowing them to enter the brain — cells labelled with bioluminescent and fluorescent
markers to enable tracking by imaging technologies — resulted in the formation of many metastatic
tumors throughout the brain, mimicking what is
seen in advanced breast cancer patients.
And so what we'll
see is we'll
see people with high levels of interferon gamma or
tumor necrosis factor alpha, you know, these are other
markers in the blood.